2021
DOI: 10.7570/jomes21049
|View full text |Cite
|
Sign up to set email alerts
|

Semi-intensive and Intensive Interdisciplinary Treatments Have Similar Effects on Metabolic Syndrome and Selected Inflammatory Markers in Adolescents with Obesity

Abstract: Background:The purpose of the present study was to compare the impact of semi-intensive and intensive interdisciplinary weight-loss therapies on the treatment of metabolic syndrome (MS) and selected inflammatory markers in adolescents with obesity. Methods: The study included 166 adolescents enrolled in two groups for 22 weeks: the intensive group (inperson aerobic and resistance exercise three times a week, and psychological and nutritional counselling once a week), or the semi-intensive group (six in-person … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 30 publications
1
0
0
Order By: Relevance
“…All of these improvements are important in controlling obesity, CVD, and subclinical atherosclerotic processes and corroborate data from the literature that demonstrate that a modest 5% reduction in body weight can have a significant impact on comorbidities associated with obesity and produce significant, clinically relevant improvements in CVD risk factors in women with obesity. Furthermore, we were able to show that in the groups with a higher and medium reduction in body weight (8% and 5%) respectively, occur a significant reduction in many cardiometabolic risk factors, which is to the findings from other similar studies (30,31).…”
Section: Discussionsupporting
confidence: 87%
“…All of these improvements are important in controlling obesity, CVD, and subclinical atherosclerotic processes and corroborate data from the literature that demonstrate that a modest 5% reduction in body weight can have a significant impact on comorbidities associated with obesity and produce significant, clinically relevant improvements in CVD risk factors in women with obesity. Furthermore, we were able to show that in the groups with a higher and medium reduction in body weight (8% and 5%) respectively, occur a significant reduction in many cardiometabolic risk factors, which is to the findings from other similar studies (30,31).…”
Section: Discussionsupporting
confidence: 87%